WebCoronavirus disease 2024 (COVID-19) is a contagious disease caused by a virus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, China, in December 2024. The disease quickly spread worldwide, resulting in the COVID-19 pandemic.. The symptoms of COVID‑19 are variable but often include fever, … WebSmall cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung. The lungs are a pair of cone-shaped breathing organs that are found in the chest. The lungs bring oxygen into the body when you breathe in and take out carbon dioxide when you breathe out. Each lung has ...
Pulmonary inflammation promoted by type-2 dendritic cells is a …
WebJun 10, 2024 · Respiratory illnesses have a massive global health impact. The following facts are concerning: Chronic obstructive pulmonary disease affects 65 million people … WebFeb 23, 2024 · Alzheimer’s is a brain disorder classified by neural damage, neuronal tangles, and amyloid plaques that interfere with brain functions. Alzheimer’s causes the brain to deteriorate. Deterioration of the brain causes symptoms such as forgetfulness, difficulty keeping up with a conversation, misplacing objects, and struggling to perform everyday … trish toledo somebody please
Small-Cell Lung Cancer: Symptoms, Causes, Tests, …
WebAug 19, 2024 · Atypical neurological symptoms; Small cell lung cancers often grow very close to the largest and most important blood vessels in the chest. ... it is difficult to know whether early detection will increase the chance of curing the disease. Treatment. Small cell lung cancer almost always has spread outside the lungs by the time it is ... WebMar 24, 2024 · With the blockade of immune checkpoints, the probability of immune-related adverse events is also increased.We present a 54-year-old female patient with advanced NSCLC. She was treated with pembrolizumab and developed a stable disease under therapy. After six cycles, she presented with massive epigastric pain to our emergency department. WebThere is lack of data addressing the intracranial (IC) efficacy of immune checkpoint inhibitors (ICIs) on brain metastases (BM) in non-small cell lung cancer (NSCLC). This patient category is underrepresented in randomized clinical trials. We retrospectively collected clinical data on patients with non-oncogenic driven NSCLC with BM who were … trish toyota